{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:29:48Z","timestamp":1790958588742,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-024-01153-0","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T07:02:08Z","timestamp":1728284528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7269-2470","authenticated-orcid":false,"given":"Sara","family":"Mato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-3058","authenticated-orcid":false,"given":"Natalia","family":"Castrej\u00f3n-de-Anta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-0057","authenticated-orcid":false,"given":"Ariadna","family":"Colmenero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Carit\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7092-9160","authenticated-orcid":false,"given":"Julia","family":"Salmer\u00f3n-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7108-7738","authenticated-orcid":false,"given":"Joan Enric","family":"Ramis-Zaldivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-9440","authenticated-orcid":false,"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-6432","authenticated-orcid":false,"given":"Luojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-0889","authenticated-orcid":false,"given":"Jaime","family":"Verd\u00fa-Amor\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1059-9766","authenticated-orcid":false,"given":"Nuria","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-8003","authenticated-orcid":false,"given":"Ana","family":"Galera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Astigarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Perez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-7595","authenticated-orcid":false,"given":"Aixiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-3675","authenticated-orcid":false,"given":"Olga","family":"Balagu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2427-9822","authenticated-orcid":false,"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"1153_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC; 2017."},{"key":"1153_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia."},{"key":"1153_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140:1229\u201353.","journal-title":"Blood."},{"key":"1153_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1182\/blood.2020008374","volume":"140","author":"AJ Olszewski","year":"2022","unstructured":"Olszewski AJ, Kurt H, Evens AM. Defining and treating high-grade B-cell lymphoma, NOS. Blood. 2022;140:943\u201354.","journal-title":"Blood."},{"key":"1153_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.pathol.2019.09.008","volume":"52","author":"CY Ok","year":"2020","unstructured":"Ok CY, Medeiros LJ. High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification. Pathology. 2020;52:68\u201377.","journal-title":"Pathology."},{"key":"1153_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/bjh.12343","volume":"162","author":"AM Perry","year":"2013","unstructured":"Perry AM, Crockett D, Dave BJ, Althof P, Winkler L, Smith LM, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: study of 39 cases. Br J Haematol. 2013;162:40\u20139.","journal-title":"Br J Haematol"},{"key":"1153_CR7","first-page":"781","volume":"39","author":"BJ Collinge","year":"2021","unstructured":"Collinge BJ, Hilton LK, Wong J, Ben-Neriah S, Rushton CK, Slack GW, et al. Characterization of the genetic landscape of high-grade B-cell lymphoma, NOS - an LLMPP project. Hematol Oncol. 2021;39:781\u20134.","journal-title":"Hematol Oncol"},{"key":"1153_CR8","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/leu.2015.34","volume":"29","author":"S Momose","year":"2015","unstructured":"Momose S, Wei\u00dfbach S, Pischimarov J, Nedeva T, Bach E, Rudelius M, et al. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum. Leukemia. 2015;29:1789\u201391.","journal-title":"Leukemia."},{"key":"1153_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.18.01314","volume":"37","author":"C Sha","year":"2019","unstructured":"Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, et al. Molecular high-grade B-cell lymphoma: Defining a poor-risk group that requires different approaches to therapy. J Clin Oncol. 2019;37:202\u201312.","journal-title":"J Clin Oncol"},{"key":"1153_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1200\/JCO.18.01583","volume":"37","author":"D Ennishi","year":"2019","unstructured":"Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, et al. Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma. J Clin Oncol. 2019;37:190\u2013201.","journal-title":"J Clin Oncol"},{"key":"1153_CR11","first-page":"2493","volume":"141","author":"W Alduaij","year":"2023","unstructured":"Alduaij W, Collinge B, Ben-Neriah S, Jiang A, Hilton LK, Boyle M, et al. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population. Blood. 2023;141:2493\u2013507.","journal-title":"Blood."},{"key":"1153_CR12","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","volume":"2","author":"LC Chong","year":"2018","unstructured":"Chong LC, Ben-Neriah S, Slack GW, Freeman C, Ennishi D, Mottok A, et al. High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology. Blood Adv. 2018;2:2755\u201365.","journal-title":"Blood Adv"},{"key":"1153_CR13","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood.2019002600","volume":"134","author":"LK Hilton","year":"2019","unstructured":"Hilton LK, Tang J, Ben-Neriah S, Alcaide M, Jiang A, Grande BM, et al. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. 2019;134:1528\u201332.","journal-title":"Blood."},{"key":"1153_CR14","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.3324\/haematol.2018.208140","volume":"105","author":"R Wagener","year":"2020","unstructured":"Wagener R, Bens S, Toprak UH, Seufert J, L\u00f3pez C, Scholz I, et al. Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of \u201cMYC-negative\u201d Burkitt lymphoma. Haematologica. 2020;105:e202\u20135.","journal-title":"Haematologica."},{"key":"1153_CR15","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","volume":"104","author":"RL King","year":"2019","unstructured":"King RL, McPhail ED, Meyer RG, Vasmatzis G, Pearce K, Smadbeck JB, et al. False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms. Haematologica. 2019;104:e248\u201351.","journal-title":"Haematologica."},{"key":"1153_CR16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44:1321\u20135.","journal-title":"Nat Genet"},{"key":"1153_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood.2019002699","volume":"135","author":"JE Ramis-Zaldivar","year":"2020","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farr\u00e9 B, Balagu\u00e9 O, Celis V, Nadeu F, Salmer\u00f3n-Villalobos J, et al. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood. 2020;135:274\u201386.","journal-title":"Blood."},{"key":"1153_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490:116\u201320.","journal-title":"Nature."},{"key":"1153_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31355-8","volume":"13","author":"B Burkhardt","year":"2022","unstructured":"Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, et al. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022;13:3881.","journal-title":"Nat Commun"},{"key":"1153_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood.2022016534","volume":"141","author":"N Thomas","year":"2023","unstructured":"Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, et al. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023;141:904\u201316.","journal-title":"Blood."},{"key":"1153_CR21","unstructured":"Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008."},{"key":"1153_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1182\/blood-2008-01-136465","volume":"112","author":"W Klapper","year":"2008","unstructured":"Klapper W, Szczepanowski M, Burkhardt B, Berger H, Rosolowski M, Bentink S, et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood. 2008;112:1374\u201381.","journal-title":"Blood."},{"key":"1153_CR23","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TFE, et al. A biologic definition of burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419\u201330.","journal-title":"N Engl J Med"},{"key":"1153_CR24","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, et al. Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med. 2006;354:2431\u201342.","journal-title":"N Engl J Med"},{"key":"1153_CR25","first-page":"1124","volume":"135","author":"W Woessmann","year":"2020","unstructured":"Woessmann W, Zimmermann M, Meinhardt A, M\u00fcller S, Hauch H, Kn\u00f6rr F, et al. Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy. Blood. 2020;135:1124\u201332.","journal-title":"Blood."},{"key":"1153_CR26","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","volume":"382","author":"V Minard-Colin","year":"2020","unstructured":"Minard-Colin V, Aup\u00e9rin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, et al. Rituximab for high-risk, mature B-cell non-Hodgkin\u2019s lymphoma in children. N Engl J Med. 2020;382:2207\u201319.","journal-title":"N Engl J Med"},{"key":"1153_CR27","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41375-021-01444-6","volume":"36","author":"AM Newman","year":"2022","unstructured":"Newman AM, Zaka M, Zhou P, Blain AE, Erhorn A, Barnard A, et al. Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia. 2022;36:781\u20139.","journal-title":"Leukemia."},{"key":"1153_CR28","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","volume":"95","author":"R Scholtysik","year":"2010","unstructured":"Scholtysik R, Kreuz M, Klapper W, Burkhardt B, Feller AC, Hummel M, et al. Detection of genomic aberrations in molecularly defined Burkitt\u2019s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica. 2010;95:2047\u201355.","journal-title":"Haematologica."},{"key":"1153_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275\u201382.","journal-title":"Blood."},{"key":"1153_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/PAS.0000000000000839","volume":"41","author":"L Colomo","year":"2017","unstructured":"Colomo L, Vazquez I, Papaleo N, Espinet B, Ferrer A, Franco C, et al. LMO2-negative expression predicts the presence of MYC translocations in aggressive B-cell lymphomas. Am J Surg Pathol. 2017;41:877\u201386.","journal-title":"Am J Surg Pathol"},{"key":"1153_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00428-021-03091-9","volume":"479","author":"I Vazquez","year":"2021","unstructured":"Vazquez I, Papaleo N, Lop J, Puiggros A, Sanchez-Gonzalez B, Diez-Feijoo R, et al. Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas. Virchows Arch. 2021;479:1073\u20138.","journal-title":"Virchows Arch"},{"key":"1153_CR32","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","volume":"30","author":"NA Johnson","year":"2012","unstructured":"Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, et al. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol. 2012;30:3452\u20139.","journal-title":"J Clin Oncol"},{"key":"1153_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1182\/blood.2023023242","volume":"144","author":"M Sureda-G\u00f3mez","year":"2024","unstructured":"Sureda-G\u00f3mez M, Iaccarino I, De Bol\u00f2s A, Meyer MA, Balsas P, Richter J, et al. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features. Blood. 2024;144:187\u2013200.","journal-title":"Blood."},{"key":"1153_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000334265","volume":"136","author":"KJ Cheung","year":"2012","unstructured":"Cheung KJ, Rogic S, Ben-Neriah S, Boyle M, Connors JM, Gascoyne RD, et al. SNP analysis of minimally evolved t(14;18)(q32;q21)-positive follicular lymphomas reveals a common copy-neutral loss of heterozygosity pattern. Cytogenet Genome Res. 2012;136:38\u201343.","journal-title":"Cytogenet Genome Res"},{"key":"1153_CR35","first-page":"965","volume":"89","author":"I Wlodarska","year":"2004","unstructured":"Wlodarska I, Stul M, De Wolf-Peeters C, Hagemeijer A. Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin\u2019s lymphoma. Haematologica. 2004;89:965\u201372.","journal-title":"Haematologica."},{"key":"1153_CR36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/hmg\/1.8.625","volume":"1","author":"S Joos","year":"1992","unstructured":"Joos S, Falk MH, Lichter P, Haluska FG, Henglein B, Lenoir GM, et al. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet. 1992;1:625\u201332.","journal-title":"Hum Mol Genet"},{"key":"1153_CR37","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/s41375-021-01251-z","volume":"35","author":"D H\u00fcbschmann","year":"2021","unstructured":"H\u00fcbschmann D, Kleinheinz K, Wagener R, Bernhart SH, L\u00f3pez C, Toprak UH, et al. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia. 2021;35:2002\u201316.","journal-title":"Leukemia."},{"key":"1153_CR38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","volume":"133","author":"BM Grande","year":"2019","unstructured":"Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, et al. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019;133:1313\u201324.","journal-title":"Blood."},{"key":"1153_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature13765","volume":"516","author":"JR Muppidi","year":"2014","unstructured":"Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE, et al. Loss of signalling via G\u03b113 in germinal centre B-cell-derived lymphoma. Nature. 2014;516:254\u20138.","journal-title":"Nature."},{"key":"1153_CR40","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1126\/science.1153629","volume":"319","author":"G Lenz","year":"2008","unstructured":"Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008;319:1676\u20139.","journal-title":"Science"},{"key":"1153_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41375-022-01802-y","volume":"37","author":"L Mansouri","year":"2023","unstructured":"Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, et al. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. 2023;37:339\u201347.","journal-title":"Leukemia."},{"key":"1153_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/leu.2017.251","volume":"32","author":"K Karube","year":"2018","unstructured":"Karube K, Enjuanes A, Dlouhy I, Jares P, Martin-Garcia D, Nadeu F, et al. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets. Leukemia. 2018;32:675\u201384.","journal-title":"Leukemia."},{"key":"1153_CR43","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378:1396\u2013407.","journal-title":"N Engl J Med"},{"key":"1153_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679\u201390.","journal-title":"Nat Med"},{"key":"1153_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37:551\u201368.","journal-title":"Cancer Cell"},{"key":"1153_CR46","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood-2011-10-388470","volume":"119","author":"W Klapper","year":"2012","unstructured":"Klapper W, Kreuz M, Kohler CW, Burkhardt B, Szczepanowski M, Salaverria I, et al. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood. 2012;119:1882\u20137.","journal-title":"Blood."},{"key":"1153_CR47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjh.17874","volume":"196","author":"J Richter","year":"2022","unstructured":"Richter J, John K, Staiger AM, Rosenwald A, Kurz K, Michgehl U, et al. Epstein\u2013Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol. 2022;196:681\u20139.","journal-title":"Br J Haematol"},{"key":"1153_CR48","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1080\/10428194.2016.1258701","volume":"58","author":"T W\u00e4sterlid","year":"2017","unstructured":"W\u00e4sterlid T, Nordstr\u00f6m L, Freiburghaus C, Pedersen M, N\u00f8rgaard P, Gang AO, et al. Frequency and clinical implications of SOX11 expression in Burkitt lymphoma. Leuk Lymphoma. 2017;58:1760\u20133.","journal-title":"Leuk Lymphoma"},{"key":"1153_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08578-3","volume":"10","author":"C L\u00f3pez","year":"2019","unstructured":"L\u00f3pez C, Kleinheinz K, Aukema SM, Rohde M, Bernhart SH, H\u00fcbschmann D, et al. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma. Nat Commun. 2019;10:1459.","journal-title":"Nat Commun"},{"key":"1153_CR50","doi-asserted-by":"crossref","unstructured":"Hilton LK, Collinge BJ, Ben-Neriah S, Alduaij W, Shaalan H, Weng A, et al. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study. Blood. 2024;144:525\u2013540.","DOI":"10.1182\/blood.2024024251"},{"key":"1153_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","volume":"8","author":"C L\u00f3pez","year":"2022","unstructured":"L\u00f3pez C, Burkhardt B, Chan JKC, Leoncini L, Mbulaiteye SM, Ogwang MD, et al. Burkitt lymphoma. Nat Rev Dis Prim. 2022;8:78.","journal-title":"Nat Rev Dis Prim"},{"key":"1153_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bjh.14812","volume":"179","author":"M Szczepanowski","year":"2017","unstructured":"Szczepanowski M, Lange J, Kohler CW, Masque-Soler N, Zimmermann M, Aukema SM, et al. Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents. Br J Haematol. 2017;179:116\u20139.","journal-title":"Br J Haematol"},{"key":"1153_CR53","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood. 2014;123:1187\u201398.","journal-title":"Blood."},{"key":"1153_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.humpath.2023.03.013","volume":"136","author":"A Shestakova","year":"2023","unstructured":"Shestakova A, Shao L, Smith LB, Ryan R, Bedell V, Murata-Collins J, et al. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases. Hum Pathol. 2023;136:34\u201343.","journal-title":"Hum Pathol"},{"key":"1153_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","volume":"149","author":"B Grygalewicz","year":"2018","unstructured":"Grygalewicz B, Woroniecka R, Rymkiewicz G, Rygier J, Borkowska K, Kotyl A, et al. The 11q-gain\/loss aberration occurs recurrently in MYC-negative Burkitt-like Lymphoma With 11q Aberration, as well as MYC-positive Burkitt lymphoma and MYC-positive high-grade B-cell lymphoma, NOS. Am J Clin Pathol. 2018;149:17\u201328.","journal-title":"Am J Clin Pathol"},{"key":"1153_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cancergen.2015.12.005","volume":"209","author":"V Havelange","year":"2016","unstructured":"Havelange V, Ameye G, Th\u00e9ate I, Callet-Bauchu E, Lippert E, Luquet I, et al. The peculiar 11q-gain\/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma. Cancer Genet. 2016;209:117\u20138.","journal-title":"Cancer Genet"},{"key":"1153_CR57","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","volume":"104","author":"B Gonzalez-Farre","year":"2019","unstructured":"Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balagu\u00e9 O, Celis V, Verdu-Amoros J, et al. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Haematologica. 2019;104:1822\u20139.","journal-title":"Haematologica."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01153-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01153-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01153-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:37:42Z","timestamp":1757119062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01153-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01153-0","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the first sentence in the Funding section has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}